RxDoctor Payments Data

Thomas Wojciechowski, MD

Family Medicine · Bowling Green, OHNPI 1447248265

Payments from drug & device makers

$3,034in general payments, 2019–2025

Across 173 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$349
  • AstraZeneca$233
  • Novo Nordisk$206
  • UCB, Inc.$176
  • Novartis$167
  • Astellas Pharma US Inc$161
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$2,91196%
  • Education$1224%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,034 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$78,198
Medicare patients
360
Services billed
1,771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban851$253,549
JanuviaSitagliptin Phosphate544$185,381
RebifInterferon Beta-1a/Albumin11$125,752
NuplazidPimavanserin Tartrate36$121,161
XareltoRivaroxaban185$58,928
MyrbetriqMirabegron179$44,401
LinzessLinaclotide65$37,100
FarxigaDapagliflozin Propanediol106$34,778
JardianceEmpagliflozin120$31,423
VraylarCariprazine Hcl38$28,715
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc254$26,044
NuedextaDextromethorphan Hbr/Quinidine32$24,098
Nurtec OdtRimegepant Sulfate20$20,969
Atorvastatin Calcium1,268$16,881
Potassium Chloride822$16,279

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$98$274,518871 claims
MerckJanuvia$27$185,381544 claims
AbbVieLinzess, Vraylar$349$65,816103 claims
Johnson & JohnsonXarelto$57$58,928185 claims
Astellas Pharma US IncMyrbetriq$161$44,401179 claims
AstraZenecaFarxiga$233$34,778106 claims
Boehringer IngelheimJardiance$64$31,423120 claims
GSKShingrix, Anoro Ellipta$31$20,32674 claims
NovartisEntresto$167$15,80947 claims
Eisai Inc.Fycompa$50$15,72626 claims
Sanofi-aventis U.S. LLCLantus$39$11,48283 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Bowling Green

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →